SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

PHVS

Pharvaris N.V.
NASDAQHealth Care

Latest close: 27.74 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 23, 2026Reported sale · Form 4Viviane Monges · $395.5KOpen the filing ↗
  2. Sep 23, 2026Notice of sale · Form 144VIVIANE ROSINE FRANCOISE BECK MONGES · Director · $395.5KOpen the filing ↗
  3. Sep 22, 2026Reported sale · Form 4Johannes Gerardus Christiaan Petrus Schikan · $29.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record31112 flagged findings
Reported transactions (Form 4)79since Apr 22, 2026 · and 40 other holdings
Corporate events (8-K)0

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-08share offering or dilution eventrecentOpen filing ↗
    “…90 days after the date of this prospectus supplement (the “restricted period”): • offer, pledge, sell, contract to sell, sell any…”
    +1 more passage from the same document
    • “…or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or…”
  • 2026-05-08listing compliance noticerecentOpen filing ↗
    “…to bankruptcy or insolvency and, in the case of a covenant defeasance, no other default has occurred and is continuing at any…”
  • 2026-05-08capital return (buybacks/dividends)recentOpen filing ↗
    “…holder of our ordinary shares. The expression “dividends distributed” includes, among other things: • distributions in cash or in…”
    +1 more passage from the same document
    • “…to a person or group of affiliated persons (other than an underwriter pursuant to this offering), of our voting securities if,…”
  • 2026-04-02share offering or dilution eventrecentOpen filing ↗
    “…The Offering closed on December 8, 2023, and the Company generated net proceeds of $ 282.0 million (€ 261.6 million), after…”
    +1 more passage from the same document
    • “…$ 18.0 million (€ 16.7 million). The Shares were sold in the Offering at the public offering price of $ 24.00 per share. The…”
  • 2026-04-02listing compliance noticerecentOpen filing ↗
    “…stock. Although we must provide shareholders with an agenda and other relevant documents for the general meeting of shareholders,…”
    +1 more passage from the same document
    • “…Dutch law does not have a regulatory regime for the solicitation of proxies and the solicitation of proxies is not a generally…”
  • 2026-04-02capital return (buybacks/dividends)recentOpen filing ↗
    “…our ordinary shares. The expression “dividends distributed” includes, among other things: • distributions in cash or in kind, deemed…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 311)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

311 filings on record, the oldest from Dec 10, 20.

Listing the 25 most recent filings of the 311 on record.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • GENERAL ATLANTIC, L.P.7.6%Jun 30, 26SCHEDULE 13G/A ↗15 co-filers on this document — the figure is the largest single stake, not their sum.
  • VIKING GLOBAL INVESTORS LP5.6%Mar 31, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • LSP V Cooperatieve U.A.4.9%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Venrock Healthcare Capital Partners III, L.P.3.8%Jun 30, 25SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • Bain Capital Life Sciences Fund, L.P.2.5%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 23, VIVIANE ROSINE FRANCOISE BECK MONGES filed notice of intent to sell up to $396K. That is about 0.02% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $396K on Sep 23, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+9 more recent notices · 7 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 23, 26Sell$396KViviane Monges↗
  • Sep 22, 26Sell$29KJohannes Gerardus Christiaan Petrus Schikan↗
  • Sep 21, 26Sell$219KDavid W. NassifCFO / CLO↗
  • Sep 17, 26Sell$765KAnne LesageChief Early Development↗
  • Sep 17, 26Sell$559KRobert Glassman↗
  • Sep 17, 26Sell$2.0MElisabeth Bjork↗
  • Sep 17, 26Sell$7.0MJohannes Gerardus Christiaan Petrus Schikan↗
  • Sep 17, 26Sell$3.5MPeng LuPresident↗
  • Sep 15, 26Sell$237KWim SouverijnsChief Commercial Officer↗
  • Sep 15, 26Sell$332KRobert Glassman↗
  • Sep 15, 26Sell$1.7MStefan Andreas AbeleChief Technical Ops Officer↗
  • Sep 15, 26Sell$55KStefan Andreas AbeleChief Technical Ops Officer↗

There are 7 more transactions in this stretch.

Stock compensation, tax and giftsshow the 21 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 12, 26Tax$4KPeng LuPresident↗
  • Oct 11, 26Tax$3KPeng LuPresident↗
  • Sep 23, 26Compensation$96KViviane Monges↗
  • Sep 22, 26Compensation$16KJohannes Gerardus Christiaan Petrus Schikan↗
  • Sep 22, 26Compensation$117KPeng LuPresident↗
  • Sep 21, 26Giftamount n/aDavid W. NassifCFO / CLO↗
  • Sep 17, 26Compensation$10.5MBerndt ModigChief Executive Officer↗
  • Sep 17, 26Compensation$263KRobert Glassman↗
  • Sep 17, 26Compensation$504KElisabeth Bjork↗
  • Sep 17, 26Compensation$317KElisabeth Bjork↗
  • Sep 17, 26Compensation$259KPeng LuPresident↗
  • Sep 15, 26Compensation$193KRobert Glassman↗
  • Sep 15, 26Compensation$738KStefan Andreas AbeleChief Technical Ops Officer↗
  • Sep 14, 26Tax$4KPeng LuPresident↗
  • Sep 14, 26Compensation$349KWim SouverijnsChief Commercial Officer↗
  • Sep 11, 26Compensation$39KPeng LuPresident↗
  • Sep 11, 26Tax$4KPeng LuPresident↗
  • Sep 10, 26Compensation$242KAnne LesageChief Early Development↗
  • Sep 9, 26Compensation$160KRobert Glassman↗
  • Sep 8, 26Compensation$39KPeng LuPresident↗
  • Aug 12, 26Tax$4KPeng LuPresident↗

The full record holds 126 transactions and goes back to Mar 17, 26.

Its sector and its market

Pharvaris N.V. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Pharvaris N.V., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Pharvaris N.V. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
311 documents on file, from Dec 10, 2020 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.